English
|
简体中文
|
繁體中文
|
한국어
|
日本語
Home
|
About us
|
Services
|
Partners
|
Events
|
Contact us
|
Login
Thursday, April 25, 2024
Press Releases for Tuesday, October 6, 2020
NEC and NEC X Announce First Graduate from Corporate Accelerator Program
18:06 HKT/SGT
6th Annual POWER WEEK ASIA Is Going Digital
16:55 HKT/SGT
Transgene, NEC and BostonGene Announce Strategic Collaboration for Two Ongoing Clinical Trials for Patients with Ovarian and Head & Neck Cancers
16:08 HKT/SGT
Transgene社・NEC・BostonGene社、治験中の卵巣がんおよび頭頸部がん患者さんの遺伝子解析で協業
16:00 HKT/SGT
eCommerce Expo Asia to announce Premium Retail Executive Summit in March 2021
14:02 HKT/SGT
エーザイ、TLR4拮抗剤エリトランおよび抗FKN 抗体E6011を用いたCOVID-19治療薬の開発を目指す産学官共同研究開発契約を締結し、非臨床研究活動を開始
14:00 HKT/SGT
JR East, Hitachi and Toyota to Develop Hybrid (Fuel Cell) Railway Vehicles Powered by Hydrogen
13:29 HKT/SGT
Moonstake 스테이킹 총액이 본격적인 서비스 개시로부터 2개월만에 5천만달러 돌파
12:00 HKT/SGT
Moonstakeのステーキング総額が53億円を突破―本格的なサービス開始から2ヶ月で達成
12:00 HKT/SGT
Moonstake's total staking asset hits $50Million - Successfully achieved in two months from the start of full-scale service
12:00 HKT/SGT
Eisai: Joint Development Agreement Aiming for Drug Discovery for COVID-19 Utilizing Eritoran and E6011 Concluded
11:07 HKT/SGT
Tianda Pharmaceuticals acquired and established a long-term relationship of Cooperation with Yeung & Young Medicare and Qi's Living
11:00 HKT/SGT
Fujitsu Develops Digital Trust Management Technology to Ensure Authenticity of Business Data
10:30 HKT/SGT
富士通、「CEATEC 2020 ONLINE」に出展
10:00 HKT/SGT
富士通研究所、ビジネスデータの真正性を保証するデジタルトラスト仲介技術を開発
10:00 HKT/SGT
トヨタと日野、北米で燃料電池大型トラックを共同で開発
07:30 HKT/SGT
Kore.ai、アジア太平洋地域における会話型AIの大きな成長を期待、日本にオフィスを開設
07:30 HKT/SGT
Toyota and Hino to Jointly Develop Class 8 Fuel Cell Electric Truck for North America
05:43 HKT/SGT
ACN Search:
Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home
|
About us
|
Services
|
Partners
|
Events
|
Login
|
Contact us
|
Cookies Policy
|
Privacy Policy
|
Disclaimer
|
Terms of Use
|
RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575